There is enormous potential in the large, noncoding transcriptome to encode disease variants. This makes RNAs appealing targets for drug discovery. Although early prospects did not have good drug-like ...

Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: A Randomized Controlled Trial ...

LEIDEN, Netherlands--(BUSINESS WIRE)--Ncardia, a leading provider of human iPSC-derived cell-based assays and services for drug discovery and development, announced today the launch of their ...

Evidence-based screening approaches have contributed to improved patient outcomes, and research continues to develop and evaluate the potential of new strategies for early cancer detection. However, ...

Purpose. The practitioner must assert what the intended purpose of the questionnaire will be. The purposes might include screening, quantifying, or diagnosing developmental delay, all of which will ...

Discover advancements in assay development and cell-based screening models with insights on AI, high-throughput screening, and toxicity detection from ELRIG Drug Discovery posters in this eBook.

COLUMBIA - The CDC has changed its guidelines for childhood development for the first time in 20 years. Local experts say getting a child properly screened will help parents determine if their kids ...

Racial Differences in Germline Genetic Testing for Prostate Cancer: A Systematic Review Approximately 1.6% of adult Americans identify as transgender (TG) or nonbinary (NB) and many take ...

In this interview, we speak to Dr. Dani Dumitriu about her latest research that investigated the development screening test scores for babies born during the COVID-19 pandemic. I am Dani Dumitriu, MD, ...